Medical intermediate condenser
By using the pneumatic pressure adjustment of piston tubes and springs and the motor-driven turbine impeller flow mechanism in the pharmaceutical intermediate condenser, the problem of excessive pressure in the condensation barrel is solved, and pressure stability and condensation efficiency are improved.
Patent Information
- Application Number
- CN202420515977.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-18
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2034-03-18
AI Technical Summary
The existing pharmaceutical intermediate condensers can easily lead to excessive pressure in the condensation barrel during the condensation process, causing the problem of rupture of the condensation barrel.
A pharmaceutical intermediate condenser including a support frame, a condensing barrel, a refrigerator, a condensing tube and a stabilizing mechanism was designed. Through the cooperation of the piston tube and the spring, the piston rod is pushed to slide with air pressure, and the spring shrinks to increase the space of the condensing barrel and reduce the Pressure and drive the turbine and impeller through the motor to make the coolant flow, and the temperature distribution is evenly distributed.
It effectively maintains the pressure stability in the condensation barrel, avoids the condensation barrel rupture, and improves the condensation efficiency of medical intermediates.
Smart Images

Figure CN221964512U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the field of condensers, in particular to a pharmaceutical intermediate condenser. Background Art
[0002] Pharmaceutical intermediates refer to compounds that are used as intermediates in the synthesis of certain drugs during the pharmaceutical process. They are usually synthesized from starting materials through a series of chemical reactions, and then go through subsequent reaction steps to finally obtain the desired drug. In the manufacture of pharmaceutical intermediates, chemical reactions usually produce some volatile organic compounds, which need to be condensed after the reaction to obtain liquid pharmaceutical intermediates.
[0003] The existing pharmaceutical intermediate condensation is to pass the gaseous pharmaceutical intermediate from a condenser tube into a condensation barrel, and use the coolant inside the condensation barrel to cool and liquefy the pharmaceutical intermediate. However, since the pharmaceutical intermediate will increase the temperature of the condensation barrel during the cooling process, the gas in the condensation barrel will expand due to the heat, which may easily lead to excessive pressure in the condensation barrel and cause the condensation barrel to rupture.
[0004] Therefore, a pharmaceutical intermediate condenser is now developed which can maintain the pressure in the condensation barrel stable during the condensation process of the pharmaceutical intermediate and avoid the condensation barrel from breaking. Utility Model Content
[0005] In order to overcome the disadvantage of existing pharmaceutical intermediate condensation that the gas in the condensation barrel expands due to heat, which easily leads to excessive pressure in the condensation barrel and causes the condensation barrel to rupture, the utility model provides a pharmaceutical intermediate condenser which can maintain a stable pressure in the condensation barrel during the condensation of the pharmaceutical intermediate and avoid the rupture of the condensation barrel.
[0006] The technical implementation scheme of the utility model is: a pharmaceutical intermediate condenser, including a support frame, a condensation barrel, a refrigerator, a condensation tube and a stabilizing mechanism, the upper part of the support frame is connected to the condensation barrel, the upper right side of the condensation barrel is connected to the refrigerator, the upper left side of the condensation barrel is connected to the condensation tube, and the condensation barrel is provided with a stabilizing mechanism capable of stabilizing the air pressure.
[0007] Optionally, a valve is also included. The condenser is rotatably connected with the valve. The valve is opened to allow the pharmaceutical intermediate to pass from the condenser into the condenser barrel.
[0008] Optionally, a handle is provided on the valve.
[0009] Optionally, a thermometer is also included. The upper left side of the condensation barrel is connected with the thermometer, and the thermometer can monitor the temperature change in the condensation barrel.
[0010] Optionally, the stabilizing mechanism includes a piston tube, a piston rod and a spring. The piston tube is connected to the upper left side of the condensation barrel, the piston tube is located on the right side of the thermometer, the piston tube is slidably connected to the piston rod, and a spring is connected between the piston rod and the piston tube. Under the action of air pressure, the piston rod is pushed to slide upward in the piston tube, and the spring is squeezed and contracted, thereby increasing the space in the condensation barrel and reducing the pressure in the condensation barrel.
[0011] Optionally, a flow mechanism is also included, which includes a motor, a turbine and an impeller. The motor is connected to the lower middle side of the condensation barrel, the turbine is connected to the motor output shaft, and the impeller is also connected to the motor output shaft. The impeller is located above the turbine. Starting the motor drives the turbine and the impeller to rotate, thereby driving the coolant in the condensation barrel to rotate.
[0012] Compared with the prior art, the utility model has the following advantages: 1. The utility model pushes the piston rod to slide upward in the piston tube under the action of air pressure, and the spring is squeezed and contracted, thereby increasing the space of the condensation barrel and reducing the pressure in the condensation barrel, thereby achieving the effect of maintaining the pressure in the condensation barrel stable during the condensation process of the pharmaceutical intermediate and avoiding the rupture of the condensation barrel.
[0013] 2. The utility model starts the motor to drive the turbine and the impeller to rotate, and drives the coolant in the condensation barrel to rotate, so as to make the coolant in the condensation barrel flow, make the temperature distribution of the coolant more uniform, and improve the condensation efficiency of the pharmaceutical intermediates. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 It is a three-dimensional structural schematic diagram of the utility model.
[0015] Figure 2 It is a cross-sectional view of the utility model.
[0016] Figure 3 It is a schematic diagram of the three-dimensional structure of the stabilizing mechanism of the utility model.
[0017] Figure 4 It is a cross-sectional view of the stabilizing mechanism of the utility model.
[0018] Figure 5 It is a schematic diagram of the three-dimensional structure of the flow mechanism of the utility model.
[0019] The meanings of the reference numerals in the figure are: 1: support frame, 2: condensation barrel, 3: refrigerator, 4: condensation tube, 5: valve, 6: thermometer, 7: stabilizing mechanism, 71: piston tube, 72: piston rod, 73: spring, 8: flow mechanism, 81: motor, 82: turbine, 83: impeller. DETAILED DESCRIPTION
[0020] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.
[0021] A pharmaceutical intermediate condenser, such as Figure 1 and Figure 2 As shown, it includes a support frame 1, a condensation barrel 2, a refrigerator 3, a condensation tube 4, a valve 5, a thermometer 6 and a stabilizing mechanism 7. The upper part of the support frame 1 is connected to the condensation barrel 2, the upper right side of the condensation barrel 2 is connected to the refrigerator 3, the upper left side of the condensation barrel 2 is connected to the condensation tube 4, the condensation tube 4 is rotatably connected to the valve 5, the valve 5 is provided with a handle for easy rotation, the upper left side of the condensation barrel 2 is connected to the thermometer 6, and the condensation barrel 2 is provided with a stabilizing mechanism 7.
[0022] like Figure 1 , Figure 3 and Figure 4 As shown, the stabilizing mechanism 7 includes a piston tube 71, a piston rod 72 and a spring 73. The piston tube 71 is connected to the upper left side of the condensation barrel 2, the piston tube 71 is located on the right side of the thermometer 6, the piston tube 71 is slidably connected to the piston rod 72, and a spring 73 is connected between the piston rod 72 and the piston tube 71.
[0023] When using the utility model, first place the support frame 1 in the condensation area of the pharmaceutical intermediate, connect the condenser tube 4 with the production pipeline of the pharmaceutical intermediate, and then start the refrigerator 3 to cool the coolant in the condensation barrel 2. At the same time, open the valve 5 to allow the pharmaceutical intermediate to pass from the condenser tube 4 into the condensation barrel 2, so that the pharmaceutical intermediate is cooled and liquefied in the condenser tube 4. The thermometer 6 can monitor the temperature change in the condensation barrel 2. When the temperature in the condensation barrel 2 increases and the air pressure increases, the piston rod 72 is pushed to slide upward in the piston tube 71 under the action of the air pressure, and the spring 73 is squeezed and contracted, thereby increasing the space of the condensation barrel 2 and reducing the pressure in the condensation barrel 2, thereby maintaining the pressure in the condensation barrel 2 stable and avoiding the rupture of the condensation barrel 2 during the condensation process of the pharmaceutical intermediate.
[0024] like Figure 1 and Figure 5 As shown, a flow mechanism 8 is also included, which includes a motor 81, a turbine 82 and an impeller 83. The motor 81 is connected to the lower middle side of the condensation barrel 2, the turbine 82 is connected to the output shaft of the motor 81, and the impeller 83 is also connected to the output shaft of the motor 81. The impeller 83 is located above the turbine 82.
[0025] By using the flow mechanism 8 of the device, the coolant in the condensation barrel 2 can flow. During the condensation process of the pharmaceutical intermediate, the motor 81 is started to drive the turbine 82 and the impeller 83 to rotate, and the coolant in the condensation barrel 2 is driven to rotate, thereby enabling the coolant in the condensation barrel 2 to flow, making the temperature distribution of the coolant more uniform, and improving the condensation efficiency of the pharmaceutical intermediate.
[0026] Although the embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes may be made to the embodiments without departing from the principles and spirit of the present invention, the scope of which is defined by the appended claims and their equivalents.
Claims
1. A pharmaceutical intermediate condenser, characterized in that: The invention comprises a support frame (1), a condensation barrel (2), a refrigerator (3), a condensation pipe (4) and a stabilizing mechanism (7); the upper part of the support frame (1) is connected to the condensation barrel (2); the upper right side of the condensation barrel (2) is connected to the refrigerator (3); the upper left side of the condensation barrel (2) is connected to the condensation pipe (4); and the stabilizing mechanism (7) capable of stabilizing the air pressure is provided on the condensation barrel (2).
2. A pharmaceutical intermediate condenser according to claim 1, characterized in that: It also includes a valve (5) which is rotatably connected to the condenser tube (4). The valve (5) is opened to allow the pharmaceutical intermediate to pass from the condenser tube (4) into the interior of the condenser barrel (2).
3. A pharmaceutical intermediate condenser according to claim 2, characterized in that: The valve (5) is provided with a handle.
4. A pharmaceutical intermediate condenser according to claim 1, characterized in that: It also includes a thermometer (6), which is connected to the upper left side of the condensation barrel (2). The thermometer (6) can monitor the temperature change in the condensation barrel (2).
5. A pharmaceutical intermediate condenser according to claim 1, characterized in that: The mechanism (7) comprises a piston tube (71), a piston rod (72) and a spring (73). The piston tube (71) is connected to the upper left side of the condensation barrel (2). The piston tube (71) is located on the right side of the thermometer (6). The piston tube (71) is slidably connected to the piston rod (72). A spring (73) is connected between the piston rod (72) and the piston tube (71). Under the action of air pressure, the piston rod (72) is pushed to slide upward in the piston tube (71). The spring (73) is squeezed and contracted, thereby increasing the space of the condensation barrel (2) and reducing the pressure in the condensation barrel (2).
6. A pharmaceutical intermediate condenser according to claim 5, characterized in that: The invention also comprises a flow mechanism (8), which comprises a motor (81), a turbine (82) and an impeller (83). The motor (81) is connected to the lower middle side of the condensation barrel (2), the turbine (82) is connected to the output shaft of the motor (81), and the impeller (83) is also connected to the output shaft of the motor (81). The impeller (83) is located above the turbine (82). When the motor (81) is started, the turbine (82) and the impeller (83) are driven to rotate, thereby driving the coolant in the condensation barrel (2) to rotate.
